Correlation Between Cyclacel Pharmaceuticals and Zenas BioPharma,
Can any of the company-specific risk be diversified away by investing in both Cyclacel Pharmaceuticals and Zenas BioPharma, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyclacel Pharmaceuticals and Zenas BioPharma, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyclacel Pharmaceuticals and Zenas BioPharma, Common, you can compare the effects of market volatilities on Cyclacel Pharmaceuticals and Zenas BioPharma, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyclacel Pharmaceuticals with a short position of Zenas BioPharma,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyclacel Pharmaceuticals and Zenas BioPharma,.
Diversification Opportunities for Cyclacel Pharmaceuticals and Zenas BioPharma,
-0.6 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Cyclacel and Zenas is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Cyclacel Pharmaceuticals and Zenas BioPharma, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zenas BioPharma, Common and Cyclacel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyclacel Pharmaceuticals are associated (or correlated) with Zenas BioPharma,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zenas BioPharma, Common has no effect on the direction of Cyclacel Pharmaceuticals i.e., Cyclacel Pharmaceuticals and Zenas BioPharma, go up and down completely randomly.
Pair Corralation between Cyclacel Pharmaceuticals and Zenas BioPharma,
Assuming the 90 days horizon Cyclacel Pharmaceuticals is expected to generate 0.75 times more return on investment than Zenas BioPharma,. However, Cyclacel Pharmaceuticals is 1.33 times less risky than Zenas BioPharma,. It trades about -0.07 of its potential returns per unit of risk. Zenas BioPharma, Common is currently generating about -0.16 per unit of risk. If you would invest 900.00 in Cyclacel Pharmaceuticals on August 24, 2024 and sell it today you would lose (206.00) from holding Cyclacel Pharmaceuticals or give up 22.89% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 80.95% |
| Values | Daily Returns |
Cyclacel Pharmaceuticals vs. Zenas BioPharma, Common
Performance |
| Timeline |
| Cyclacel Pharmaceuticals |
| Zenas BioPharma, Common |
Cyclacel Pharmaceuticals and Zenas BioPharma, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cyclacel Pharmaceuticals and Zenas BioPharma,
The main advantage of trading using opposite Cyclacel Pharmaceuticals and Zenas BioPharma, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyclacel Pharmaceuticals position performs unexpectedly, Zenas BioPharma, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zenas BioPharma, will offset losses from the drop in Zenas BioPharma,'s long position.| Cyclacel Pharmaceuticals vs. Absci Corp | Cyclacel Pharmaceuticals vs. Larimar Therapeutics | Cyclacel Pharmaceuticals vs. InMed Pharmaceuticals | Cyclacel Pharmaceuticals vs. Kronos Bio |
| Zenas BioPharma, vs. enGene Holdings Common | Zenas BioPharma, vs. GRI Bio | Zenas BioPharma, vs. Prime Medicine, Common | Zenas BioPharma, vs. Amylyx Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |